Funder: National Institutes of Health
Due Dates: March 13, 2025 | March 13, 2026 (AIDS - New/Renewal/Resubmission/Revision)
Funding Amounts: Up to $2,500,000 direct costs/year; project period up to 5 years; 1–2 awards expected per cycle.
Summary: Supports multi-component, multi-disciplinary research projects advancing HIV/AIDS prophylactic vaccine discovery, including preclinical evaluation in non-human primate models.
Key Information: Clinical trials are not allowed; applications must include immunogenicity data and a minimum of two integrated research projects.